US 10376598
Targeted therapeutics
granted A61KA61K47/545A61K49/00
Quick answer
US patent 10376598 (Targeted therapeutics) held by Madrigal Pharmaceuticals, Inc. expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Madrigal Pharmaceuticals, Inc.
- Grant date
- Tue Aug 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K47/545, A61K49/00